Faup v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided May 22, 2017·No. 12-87·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 12-87V Filed: April 21, 2017

* * * * * * * * * * * * * * LISA FAUP, parent of A.F., a minor, * * Petitioner, * Special Master Sanders * v. * * SECRETARY OF HEALTH * Interim Attorneys’ Fees and Costs; AND HUMAN SERVICES, * Attorney Hourly Rate; Expert Hourly Rate. * Respondent. * * * * * * * * * * * * * * *

Sylvia Chin-Caplan, Law Office of Sylvia Chin-Caplan, Boston, MA, for Petitioner. Jennifer L. Reynaud, United States Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1

On February 8, 2017, Lisa Faup (“Petitioner”) retained Ms. Sylvia Chin-Caplan as her counsel. Consented Mot. Substitute Att’y, ECF No. 75. On that day, Petitioner’s former counsel, Mr. Ronald C. Homer, moved for an award of interim attorneys’ fees and costs. Mot. Interim Att’ys’ Fees, ECF No. 74. After careful consideration, the undersigned has determined to grant the request in full.

I. PROCEDURAL HISTORY

On February 9, 2012, Lisa Faup (“Petitioner”) filed a petition as the parent of A.F., a minor, pursuant to the National Vaccine Injury Compensation Program,2 42 U.S.C. §§ 300aa-10

1 This decision shall be posted on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2012)). As provided by Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). 2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755 (“the Vaccine Act” or “Act”). Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). to -34 (2012). Petitioner alleged that A.F. suffered from a “rheumatologic injury” as a result of the administration of Diphtheria-Tetanus-acellular-Pertussis (“DTaP”) and inactivated polio (“IPV”) vaccinations on March 13, 2009. Pet. 1, ECF No. 1. Petitioner was represented by Mr. Homer at the time of her filing. Id. The case was initially assigned to Special Master Sandra D. Lord. Not. Assignment, ECF No. 4.

Petitioner subsequently filed medical records over the months following her petition. See Docket Rep. Respondent filed his Rule 4(c) Report on June 18, 2012, recommending against compensation under the Vaccine Act. Resp’t Rep., ECF No. 12. Respondent argued that Petitioner could neither show that A.F. suffered from the residual effects of her injury for more than six months, nor did Petitioner provide a medical theory connecting A.F.’s vaccinations to her injury. Id. at 12-13. Respondent claimed that Petitioner’s case relied upon a “‘post hoc ergo propter hoc’ line of reasoning, [which is] unpersuasive in Program cases, and cannot satisfy petitioner’s burden of proof.” Id. at 13.

Special Master Lord held a status conference on June 29, 2012. Min. Entry, dated June 29, 2012. Petitioner argued during the status conference that she satisfied the six-month requirement as A.F. took prescription medication for more than six months. Order, ECF No. 14. Special Master Lord stated that “this issue needed to be resolved before moving forward with the case.” Id. Special Master Lord ordered Respondent to submit a motion for summary judgment, “at a minimum, address[ing] the question whether an injury may be deemed to have persisted for a period of six months when the symptoms are ameliorated by medication before the expiration of six months, but the medication continues to be prescribed and administered beyond the six- month period.” Id.

On August 17, 2012, Respondent submitted his Motion for Summary Judgment. Mot. Summ. J., ECF No. 15. In his Motion, Respondent argued that medicinal amelioration of symptoms is insufficient to satisfy the Vaccine Act’s six-month requirement. Id. at 9-10. Because the medical records showed that A.F.’s symptoms were resolved within five months of onset, Respondent argued, there existed no “genuine issue of material fact,” and he should therefore prevail on his Motion for Summary Judgment. Id. at 8-9.

On September 10, 2012, Chief Special Master Patricia E. Campbell-Smith was assigned to the case. Order Reassigning Case, ECF No. 16. Almost a month later, on October 5, 2012, Petitioner filed an amended petition. Am. Pet., ECF No. 19. Petitioner alleged that A.F. suffered from “systemic juvenile arthritis”3 and included an allegation that A.F. suffered “the residual effects of her injury for more than six months after the administration of the vaccine.” Id. at 1, 15.

On the same day, October 5, 2012, Petitioner submitted her response to Respondent’s Motion for Summary Judgment. Pet’r’s Opp’n, ECF No. 20. Petitioner argued that A.F.’s “symptoms persisted and her laboratory values were abnormal for more than six months

3 A.F.’s diagnosis in her medical records is referred to as “systemic juvenile idiopathic arthritis” [hereinafter “JIA”]. See Second Mot. Summ. J. 1 n.1 (noting that the amended petition may contain a typographical error).

2 following her vaccines.” Id. at 16. Furthermore, Petitioner claimed that A.F. suffered from the effects of her Methotrexate treatment until May 2010 and experienced “vaccine-induced emotional distress and pain and suffering for approximately one year after receiving her vaccines.” Id. Petitioner additionally argued that she alternatively fulfilled the severity requirement of the Vaccine Act. Id. at 21. Petitioner claimed that A.F. underwent “general anesthesia and a bone marrow biopsy,” which satisfies the Vaccine Act’s requirements that a claim may proceed if an injury results in inpatient hospitalization and surgical intervention. Id. (citing § 11(c)(1)(D)(iii)).

Respondent replied to Petitioner’s Response on October 22, 2012. Resp’t Resply, ECF No. 22. Respondent argued that A.F.’s laboratory tests, the side effects of her medication, and “aversion to needles” fail to meet the six-month requirement of the Vaccine Act. Id. at 2-5. Furthermore, Respondent argued, Petitioner’s bone marrow biopsy does not qualify as an “inpatient hospitalization and surgical intervention” under § 11(c)(1). Id. at 5.

Chief Special Master Campbell-Smith issued her Ruling on Respondent’s Motion for Summary Judgment on February 26, 2013. Ruling Mot. Summ. J., ECF No. 23. Chief Special Master Campbell-Smith agreed with Respondent that Petitioner could not show that A.F. suffered the residual effects of her injury “by pointing to either the health impact of A.F.’s prescribed medication or her attendant emotional response that manifested as a fear of receiving further shots.” Id. at 6. Chief Special Master Campbell-Smith however disagreed with Respondent as to whether A.F.’s bone marrow biopsy fulfills the criterion of § 11(c)(1). Id. at 7- 8. Petitioner’s procedure was performed on an outpatient basis, Chief Special Master Campbell- Smith found, and a bone marrow biopsy does not quality as a “surgical procedure.” Id. “Nonetheless,” Chief Special Master Campbell-Smith ordered Petitioner “to offer a medical opinion on this matter.” Id. at 8.

Free access — add to your briefcase to read the full text and ask questions with AI

Faup v. Secretary of Health and Human Services, (uscfc 2017).

Faup v. Secretary of Health and Human Services (Faup v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related